SCHEMBL6021992

SCHEMBL6021992

CCCCCCSc1nc(C2CC2)cc(C(OCC)OCC)n1.CCCCCCSc1nc(C=O)cc(C2CC2)n1

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 2/20 0.32
CHRM1 P11229 4/20 0.31
CHRM2 P08172 1/20 0.30
CHRM3 P20309 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5045840 0.91 SMN1; SMN2 (0.35) GPR84CHRM1CHRM2CHRM3
SCHEMBL5046511 0.87 SMN1; SMN2 (0.37) GPR84CHRM1
SCHEMBL6022699 0.79 ADORA3 (0.31)
SCHEMBL5046187 0.74 GPR84 (0.46) GPR84
SCHEMBL5049082 0.71 SMN1; SMN2 (0.38) GPR84
SCHEMBL5049080 0.70 GPR84 (0.49) GPR84
SCHEMBL5049134 0.69 SMN1; SMN2 (0.39) GPR84
SCHEMBL5692459 0.68 TLR8 (0.41)
SCHEMBL5049122 0.67 GPR84 (0.44) GPR84
SCHEMBL5049907 0.67 SMN1; SMN2 (0.38) GPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1725239-A1 4-(SULFANYL-PYRIMIDIN-4-YLMETHYL)-MORPHOLINE DERIVATIVES AND RELATED COMPOUNDS AS GABA RECEPTOR LIGANDS FOR THE TREATMENT OF ANXIETY, DEPRESSION AND EPILEPSY F.HOFFMANN-LA ROCHE AG (CH) 2006-11-29 EP disclosed
WO-2005094828-A1 4- (SULFANYL-PYRIMIDIN-4-YLMETHYL) -MORPHOLINE DERIVATIVES AND RELATED COMPOUNDS AS GABA RECEPTOR LIGANDS FOR THE TREATMENT OF ANXIETY, DEPRESSION AND EPILEPSY F. HOFFMANN-LA ROCHE AG (CH) 2005-10-13 WO disclosed